Risk factors for peritoneal carcinomatosis in gastric cancer patients, and outcomes following resection and hyperthermic intraperitoneal chemotherapy (HIPEC).

被引：0
|
作者：
Kim, Ki Won
Chow, Oliver
Parikh, Kunal
Blank, Sima
Jibara, Ghalib
Labow, Daniel M.
Hiotis, Spiros P.
机构：
[1] Mt Sinai Sch Med, New York, NY USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA
[3] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14656
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis
    Rihuete Caro, Cristina
    Manzanedo, Israel
    Pereira, Fernando
    Carrion-Alvarez, Lucia
    Serrano, Angel
    Perez-Viejo, Estibalitz
    EJSO, 2018, 44 (11): : 1805 - 1810
  • [2] Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis arising from gastric cancer
    Piso, P.
    Glockzin, G.
    Schlitt, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [3] Outcomes Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy with and without Diaphragmatic Resection in Patients with Peritoneal Carcinomatosis
    Nikiforchin, A.
    Gushchin, V.
    Baron, E.
    Sittig, M.
    Nieroda, C.
    Sardi, A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S110 - S111
  • [4] Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy
    Kim, Ki Won
    Chow, Oliver
    Parikh, Kunal
    Blank, Sima
    Jibara, Ghalib
    Kadri, Hena
    Labow, Daniel M.
    Hiotis, Spiros P.
    AMERICAN JOURNAL OF SURGERY, 2014, 207 (01): : 78 - 83
  • [5] Peritoneal carcinomatosis from gastric cancer: resection, chemotherapy, HIPEC
    Lordick, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 5 - 5
  • [6] Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis
    Detroz, B
    Laurent, S
    Honoré, P
    Blaffart, E
    Limet, R
    Meurisse, M
    ACTA CHIRURGICA BELGICA, 2004, 104 (04) : 377 - 383
  • [7] Reply to "Peritoneal carcinomatosis in patients with gastric cancer and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy"
    Graziosi, Luigina
    Marino, Eliabetta
    Donini, Annibale
    AMERICAN JOURNAL OF SURGERY, 2014, 208 (01): : 158 - 159
  • [8] Survival outcomes with curative intent hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer with peritoneal metastasis
    Joung, Bowon
    Castillo, Dani Ran
    Park, Daniel
    Al-Manaseer, Farris
    Jeon, Won Jin
    Yang, Chieh
    Burke, Linnea
    Woo, Yanghee
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Hyperthermic intraperitoneal chemotherapy (HIPEC). Mechanisms of action and the role of HIPEC in the treatment of peritoneal carcinomatosis
    Bartos, Adrian
    Bartos, Dana
    Herdean, Andrei
    Szabo, Bianca
    Militaru, Claudia
    Raluca, Stoian
    Calin, Mitre
    Iancu, Cornel
    Breazu, Caius
    ANNALI ITALIANI DI CHIRURGIA, 2018, 89 (06) : 513 - 527
  • [10] Prehabilitation to improve postoperative outcomes in patients with peritoneal carcinomatosis undergoing hyperthermic intraperitoneal chemotherapy (HIPEC): A scoping review
    Strijker, D.
    Meijerink, W. J. H. J.
    Bremers, A. J. A.
    de Reuver, P.
    van Laarhoven, C. J. H. M.
    van den Heuvel, B.
    EJSO, 2022, 48 (03): : 657 - 665
12345